Travere Therapeutics, Inc. (TVTX)
USD 15.0
(-9.42%)
USD 15.0
(-9.42%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 588.1 Million USD | -6.61% |
| 2022 | 629.73 Million USD | 32.71% |
| 2021 | 474.52 Million USD | 19.76% |
| 2020 | 396.22 Million USD | 3.29% |
| 2019 | 383.6 Million USD | -1.87% |
| 2018 | 390.9 Million USD | 72.05% |
| 2017 | 227.21 Million USD | 4.46% |
| 2016 | 217.51 Million USD | 2.39% |
| 2015 | 212.42 Million USD | 22.99% |
| 2014 | 172.72 Million USD | 345.04% |
| 2013 | 38.81 Million USD | 569.26% |
| 2012 | 5.79 Million USD | 8556.76% |
| 2011 | 66.98 Thousand USD | 4.32% |
| 2010 | 64.21 Thousand USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 33.85 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 535.97 Million USD | -9.08% |
| 2024 Q1 | 589.47 Million USD | 0.23% |
| 2024 Q3 | 534.86 Million USD | -0.21% |
| 2023 Q4 | 588.1 Million USD | 6.33% |
| 2023 Q1 | 619.09 Million USD | -1.69% |
| 2023 FY | 588.1 Million USD | -6.61% |
| 2023 Q3 | 553.08 Million USD | -10.78% |
| 2023 Q2 | 619.94 Million USD | 0.14% |
| 2022 Q3 | 625.53 Million USD | 0.44% |
| 2022 Q1 | 620.26 Million USD | 30.71% |
| 2022 Q2 | 622.78 Million USD | 0.41% |
| 2022 Q4 | 629.73 Million USD | 0.67% |
| 2022 FY | 629.73 Million USD | 32.71% |
| 2021 Q2 | 414.46 Million USD | 3.27% |
| 2021 FY | 474.52 Million USD | 19.76% |
| 2021 Q1 | 401.35 Million USD | 1.29% |
| 2021 Q3 | 467.7 Million USD | 12.85% |
| 2021 Q4 | 474.52 Million USD | 1.46% |
| 2020 Q4 | 396.22 Million USD | 1.39% |
| 2020 Q1 | 347.31 Million USD | -9.46% |
| 2020 FY | 396.22 Million USD | 3.29% |
| 2020 Q2 | 360.04 Million USD | 3.67% |
| 2020 Q3 | 390.8 Million USD | 8.54% |
| 2019 Q3 | 367.85 Million USD | -0.71% |
| 2019 FY | 383.6 Million USD | -1.87% |
| 2019 Q1 | 381.95 Million USD | -2.29% |
| 2019 Q2 | 370.48 Million USD | -3.0% |
| 2019 Q4 | 383.6 Million USD | 4.28% |
| 2018 Q1 | 201.31 Million USD | -11.4% |
| 2018 Q4 | 390.9 Million USD | -1.56% |
| 2018 Q3 | 397.12 Million USD | 95.48% |
| 2018 FY | 390.9 Million USD | 72.05% |
| 2018 Q2 | 203.15 Million USD | 0.91% |
| 2017 Q3 | 215.99 Million USD | 2.22% |
| 2017 Q1 | 209.44 Million USD | -3.71% |
| 2017 Q2 | 211.3 Million USD | 0.89% |
| 2017 FY | 227.21 Million USD | 4.46% |
| 2017 Q4 | 227.21 Million USD | 5.2% |
| 2016 Q3 | 224.82 Million USD | 2.38% |
| 2016 FY | 217.51 Million USD | 2.39% |
| 2016 Q2 | 219.59 Million USD | 16.89% |
| 2016 Q4 | 217.51 Million USD | -3.25% |
| 2016 Q1 | 187.86 Million USD | -11.56% |
| 2015 FY | 212.42 Million USD | 22.99% |
| 2015 Q1 | 247.42 Million USD | 43.25% |
| 2015 Q2 | 274.35 Million USD | 10.89% |
| 2015 Q3 | 220.61 Million USD | -19.59% |
| 2015 Q4 | 212.42 Million USD | -3.71% |
| 2014 Q4 | 172.72 Million USD | 10.63% |
| 2014 FY | 172.72 Million USD | 345.04% |
| 2014 Q3 | 156.11 Million USD | 1.07% |
| 2014 Q2 | 154.46 Million USD | 19.34% |
| 2014 Q1 | 129.44 Million USD | 233.52% |
| 2013 Q3 | 27.16 Million USD | 144.11% |
| 2013 Q1 | 8.17 Million USD | 11804.32% |
| 2013 Q4 | 38.81 Million USD | 42.85% |
| 2013 FY | 38.81 Million USD | 569.26% |
| 2013 Q2 | 11.12 Million USD | 36.19% |
| 2012 Q4 | 68.65 Thousand USD | 0.97% |
| 2012 FY | 5.79 Million USD | 8556.76% |
| 2012 Q1 | 66.98 Thousand USD | 1.94% |
| 2012 Q2 | 67.48 Thousand USD | 0.75% |
| 2012 Q3 | 67.98 Thousand USD | 0.74% |
| 2011 Q2 | 64.71 Thousand USD | 0.78% |
| 2011 Q1 | 64.21 Thousand USD | 0.0% |
| 2011 FY | 66.98 Thousand USD | 4.32% |
| 2011 Q4 | 65.71 Thousand USD | 0.77% |
| 2011 Q3 | 65.21 Thousand USD | 0.77% |
| 2010 FY | 64.21 Thousand USD | 0.0% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q2 | 57.5 Thousand USD | 0.0% |
| 2010 Q3 | 61.13 Thousand USD | 6.31% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | 49.9 Thousand USD | 39.17% |
| 2009 Q3 | 35.85 Thousand USD | 1.41% |
| 2009 Q2 | 35.35 Thousand USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | 57.36 Thousand USD | 0.0% |
| 2008 Q3 | - USD | -100.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | 33.85 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -75.147% |
| Alkermes plc | 933.53 Million USD | 37.003% |
| Agenus Inc. | 462.29 Million USD | -27.214% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 85.481% |
| Aptorum Group Limited | 5.25 Million USD | -11087.603% |
| Ardelyx, Inc. | 130.76 Million USD | -349.747% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -22.934% |
| Bicycle Therapeutics plc | 224.41 Million USD | -162.064% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -351.657% |
| ChromaDex Corporation | 26.5 Million USD | -2118.587% |
| Chimerix, Inc. | 19.74 Million USD | -2878.491% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1571.834% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -710.428% |
| CRISPR Therapeutics AG | 346.76 Million USD | -69.596% |
| Precision BioSciences, Inc. | 140.92 Million USD | -317.331% |
| Dyadic International, Inc. | 2.34 Million USD | -25025.617% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3516.202% |
| Fortress Biotech, Inc. | 165.93 Million USD | -254.409% |
| Lantern Pharma Inc. | 2.73 Million USD | -21366.104% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -722.752% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -16566.161% |
| Incyte Corporation | 1.59 Billion USD | 63.065% |
| IO Biotech, Inc. | 17.55 Million USD | -3249.869% |
| Jaguar Health, Inc. | 45.86 Million USD | -1182.22% |
| Novavax, Inc. | 2.57 Billion USD | 77.137% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1530.992% |
| Opthea Limited | 264.6 Million USD | -122.26% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -349.94% |
| ContextLogic Inc. | 206 Million USD | -185.487% |
| MiMedx Group, Inc. | 96.33 Million USD | -510.509% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1124.653% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -16565.396% |
| NextCure, Inc. | 14.99 Million USD | -3821.471% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -14449.802% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -8707.893% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1158.27% |
| Vaxcyte, Inc. | 167.44 Million USD | -251.213% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1668.245% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -150.029% |
| Pharming Group N.V. | 244.07 Million USD | -140.954% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -4832.922% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -360.207% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8800.835% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8800.835% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -613.432% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -8752.973% |
| Acelyrin, Inc. | 86.35 Million USD | -581.045% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -45165.12% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3990.013% |
| Summit Therapeutics Inc. | 125.25 Million USD | -369.517% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -6104.273% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1018.683% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -755.087% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -288.156% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -29966.616% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -43934.056% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -159.268% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -6178.456% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -158.569% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -18.927% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5288.519% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2037.701% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -4758.469% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -20.859% |
| Immix Biopharma, Inc. | 3.72 Million USD | -15701.647% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1455.334% |
| MEI Pharma, Inc. | 8.35 Million USD | -6938.935% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1926.893% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -69.199% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -303.172% |
| Fortress Biotech, Inc. | 165.93 Million USD | -254.409% |
| Precigen, Inc. | 41.64 Million USD | -1312.215% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1077.855% |
| AlloVir, Inc. | 45.01 Million USD | -1206.46% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -351.217% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -326.78% |
| ImmuCell Corporation | 18.81 Million USD | -3025.709% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1983.551% |
| Onconetix, Inc. | 23.18 Million USD | -2437.017% |
| PureTech Health plc | 125.58 Million USD | -368.298% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -6470.983% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1615.486% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -23953.292% |
| Seer, Inc. | 39.36 Million USD | -1393.974% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -851.1% |
| Innoviva, Inc. | 568.55 Million USD | -3.439% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2059.92% |
| ESSA Pharma Inc. | 3.49 Million USD | -16726.64% |
| GlycoMimetics, Inc. | 6.9 Million USD | -8420.671% |
| GT Biopharma, Inc. | 6.63 Million USD | -8766.32% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -122.438% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -115.986% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -599.906% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -5917.015% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2064.61% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -18131.382% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -697.244% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3620.122% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5227.171% |
| Soligenix, Inc. | 7.27 Million USD | -7983.997% |
| Century Therapeutics, Inc. | 175.94 Million USD | -234.261% |
| Kura Oncology, Inc. | 51.66 Million USD | -1038.367% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -384.905% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -14129.446% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -8791.985% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -132.822% |
| Autolus Therapeutics plc | 263.9 Million USD | -122.845% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -5510.599% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -561.824% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1153.978% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -66.669% |
| GRI Bio, Inc. | 2.69 Million USD | -21705.821% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -72542.527% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1791.554% |
| IGM Biosciences, Inc. | 220.17 Million USD | -167.105% |
| INmune Bio, Inc. | 18.86 Million USD | -3017.925% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -129.299% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2107.444% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21534.112% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -17828.516% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -906.078% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -511.594% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -122.148% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 28.544% |
| Verastem, Inc. | 71.18 Million USD | -726.161% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1095.915% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1424.452% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1101.878% |
| Histogen Inc. | 5.69 Million USD | -10223.03% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -13309.849% |
| Surrozen, Inc. | 8.14 Million USD | -7120.417% |
| Organovo Holdings, Inc. | 2.74 Million USD | -21301.128% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -187278.687% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -945.89% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3461.67% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1050.819% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -71023.568% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -364.078% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5338.555% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -289.759% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -22455.627% |
| Apollomics, Inc. | 14.15 Million USD | -4055.324% |
| Amarin Corporation plc | 279.58 Million USD | -110.347% |
| Mesoblast Limited | 188.79 Million USD | -211.499% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4056.792% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -225.3% |
| Synaptogenix, Inc. | 5.52 Million USD | -10535.795% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -8746.315% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -245.723% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6772.616% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -33364.512% |
| Exelixis, Inc. | 678.44 Million USD | 13.316% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2366.668% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -258.499% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 1.028% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5406.477% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -36121.804% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1410.784% |
| Gritstone bio, Inc. | 125.91 Million USD | -367.049% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3907.243% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -11457.204% |
| Avid Bioservices, Inc. | 275.66 Million USD | -113.337% |
| Insmed Incorporated | 1.66 Billion USD | 64.61% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -7543.634% |
| MediWound Ltd. | 27.18 Million USD | -2063.177% |
| OmniAb, Inc. | 87.4 Million USD | -572.887% |
| Alector, Inc. | 487.66 Million USD | -20.595% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -45.766% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3091.875% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1432.596% |
| Zai Lab Limited | 240.17 Million USD | -144.862% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 6.659% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1912.191% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -518.554% |
| Immunic, Inc. | 25.36 Million USD | -2218.287% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -749.418% |
| Veracyte, Inc. | 93.71 Million USD | -527.517% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -22375.219% |
| FibroGen, Inc. | 585.72 Million USD | -0.405% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3283.208% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -89951.234% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -10298.857% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 92.319% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -7073.737% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -599.939% |
| TG Therapeutics, Inc. | 169.08 Million USD | -247.815% |
| Galecto, Inc. | 5.89 Million USD | -9874.61% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -6999.264% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 77.54% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1940.466% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -4559.718% |
| XBiotech Inc. | 8.39 Million USD | -6903.728% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3907.243% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1005.873% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -61.965% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2087.558% |
| Theravance Biopharma, Inc. | 169 Million USD | -247.982% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 51.62% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -17.52% |
| Vaxxinity, Inc. | 30.94 Million USD | -1800.54% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 39.526% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -9651.162% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 21.085% |
| NexImmune, Inc. | 5.08 Million USD | -11467.194% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -158250.162% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -19026.246% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 91.725% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -11310.547% |
| Scopus BioPharma Inc. | 7.45 Million USD | -7789.305% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2136.643% |
| Ainos, Inc. | 7.39 Million USD | -7853.547% |
| Pluri Inc. | 34.11 Million USD | -1624.036% |
| Prothena Corporation plc | 135.01 Million USD | -335.577% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -141.915% |
| Celularity Inc. | 102.92 Million USD | -471.368% |
| Rallybio Corporation | 9.43 Million USD | -6132.546% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2305.821% |
| MeiraGTx Holdings plc | 319.99 Million USD | -83.787% |
| Omeros Corporation | 403.25 Million USD | -45.84% |
| Humacyte, Inc. | 114.67 Million USD | -412.834% |
| Immunocore Holdings plc | 228.15 Million USD | -157.761% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -11963.651% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -666.358% |
| Blueprint Medicines Corporation | 918.64 Million USD | 35.981% |
| CalciMedica, Inc. | 4.02 Million USD | -14500.372% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3269.832% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -281.531% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -585.299% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -111.705% |
| Pulmatrix, Inc. | 15.96 Million USD | -3584.163% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3628.542% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2290.08% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -134.483% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1058.002% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 51.422% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1750.37% |
| Nutriband Inc. | 1.07 Million USD | -54408.54% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5430.923% |
| Vor Biopharma Inc. | 59.1 Million USD | -895.031% |
| Roivant Sciences Ltd. | 773.95 Million USD | 24.013% |
| Evogene Ltd. | 17.99 Million USD | -3169.055% |
| ProKidney Corp. | 29.21 Million USD | -1912.948% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -717.048% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -83320.877% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 68.866% |
| CorMedix Inc. | 11.91 Million USD | -4834.773% |
| BioLineRx Ltd. | 50.7 Million USD | -1059.921% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -293.488% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -564.966% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1096.255% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1787.831% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3174.151% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -371.856% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -10301.539% |
| MediciNova, Inc. | 3.89 Million USD | -15012.296% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3117.37% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -38996.328% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16608.036% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -48.04% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1816.269% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 78.392% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3584.394% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1784.885% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -902.152% |
| Absci Corporation | 58.3 Million USD | -908.684% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2987.479% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1734.268% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -696.996% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -572.248% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1641.495% |
| Allakos Inc. | 74.79 Million USD | -686.308% |
| Imunon, Inc. | 8.53 Million USD | -6794.18% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2513.675% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -412.231% |
| BioAtla, Inc. | 48.98 Million USD | -1100.553% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5406.477% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -21062.397% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -350.295% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4037.2% |
| XOMA Corporation | 145.58 Million USD | -303.972% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1646.927% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -755.311% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1761.262% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -851.269% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1207.913% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1115.039% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -20391.394% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -7108.896% |
| Akari Therapeutics, Plc | 4.58 Million USD | -12729.472% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3216.408% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 64.346% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -145503.207% |
| UroGen Pharma Ltd. | 243.52 Million USD | -141.498% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -83.16% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -21196.058% |
| Orgenesis Inc. | 35.53 Million USD | -1554.996% |
| Entera Bio Ltd. | 1.37 Million USD | -42547.063% |
| GH Research PLC | 6.7 Million USD | -8676.347% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -8548.574% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3023.887% |
| Xencor, Inc. | 283.55 Million USD | -107.401% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -19597.489% |
| Replimune Group, Inc. | 113.21 Million USD | -419.461% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -15553.006% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -468.051% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -145503.207% |
| Portage Biotech Inc. | 4.45 Million USD | -13115.798% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -38996.328% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2451.423% |
| OncoCyte Corporation | 49.29 Million USD | -1092.955% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -14116.358% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -73644.802% |
| Purple Biotech Ltd. | 10 Million USD | -5778.091% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -10064.241% |
| scPharmaceuticals Inc. | 57.26 Million USD | -927.057% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -4647.352% |
| HilleVax, Inc. | 78.9 Million USD | -645.293% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -11545.604% |
| Tharimmune, Inc. | 1.81 Million USD | -32301.548% |
| Genprex, Inc. | 3.25 Million USD | -17972.078% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2068.601% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -11131.914% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -285386.893% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -163923.506% |
| OKYO Pharma Limited | 7.42 Million USD | -7825.013% |
| Savara Inc. | 37.19 Million USD | -1481.262% |
| Curis, Inc. | 57.61 Million USD | -920.799% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2133.598% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1400.271% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -40627.355% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2724.838% |
| BeiGene, Ltd. | 2.23 Billion USD | 73.672% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2662.37% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -124.127% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2664.421% |
| Erasca, Inc. | 78.61 Million USD | -648.118% |
| bluebird bio, Inc. | 424.62 Million USD | -38.5% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -89652.187% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 68.884% |
| DBV Technologies S.A. | 42.8 Million USD | -1274.072% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -89652.187% |
| Moderna, Inc. | 4.57 Billion USD | 87.137% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -8307.477% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -35413.466% |
| Molecular Templates, Inc. | 31.17 Million USD | -1786.699% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3345.243% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -372.353% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2043.467% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1513.186% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -957.074% |
| MacroGenics, Inc. | 154.2 Million USD | -281.372% |
| RenovoRx, Inc. | 4.46 Million USD | -13068.451% |
| Adicet Bio, Inc. | 37.12 Million USD | -1484.329% |
| Prime Medicine, Inc. | 60.78 Million USD | -867.593% |
| Aditxt, Inc. | 28.53 Million USD | -1961.237% |
| Adagene Inc. | 45.16 Million USD | -1201.996% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -325356.417% |
| Quantum-Si incorporated | 26.63 Million USD | -2108.34% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 15.692% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -19229.991% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -411.567% |
| SciSparc Ltd. | 1.59 Million USD | -36771.661% |
| Vericel Corporation | 127.7 Million USD | -360.517% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10468.09% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -588.983% |
| Generation Bio Co. | 171.63 Million USD | -242.657% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -4991.801% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1305.902% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -132.73% |
| Invivyd, Inc. | 51.71 Million USD | -1037.244% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -539.402% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -8940.435% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -678.986% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -57500.686% |
| 2seventy bio, Inc. | 310.12 Million USD | -89.634% |
| ADMA Biologics, Inc. | 193.97 Million USD | -203.183% |
| Clene Inc. | 38.95 Million USD | -1409.853% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1527.613% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -128.855% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16608.036% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -209.1% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -4728.566% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -196.539% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -4722.572% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1122.388% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1012.967% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -59.01% |
| Evaxion Biotech A/S | 17.61 Million USD | -3238.179% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -265.443% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -283.914% |
| Trevena, Inc. | 48.26 Million USD | -1118.563% |
| Surrozen, Inc. | 8.14 Million USD | -7120.417% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2623.329% |
| Cingulate Inc. | 10.36 Million USD | -5576.196% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -21285.564% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1477.022% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -16297.594% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4372.266% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -85.404% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2266.707% |
| Clearmind Medicine Inc. | 3.61 Million USD | -16190.906% |
| Kronos Bio, Inc. | 54.2 Million USD | -985.041% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1150.139% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2483.963% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2830.113% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2493.452% |
| ImmunityBio, Inc. | 1.09 Billion USD | 46.065% |
| Korro Bio, Inc. | 51.75 Million USD | -1036.387% |
| Kineta, Inc. | 7.22 Million USD | -8043.215% |
| BioVie Inc. | 9.7 Million USD | -5961.586% |
| Codexis, Inc. | 49.94 Million USD | -1077.478% |
| Celularity Inc. | 102.92 Million USD | -471.368% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -511.035% |
| Celcuity Inc. | 51.45 Million USD | -1043.056% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -170268.836% |
| Cibus, Inc. | 206.11 Million USD | -185.325% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1284.586% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2132.822% |
| IN8bio, Inc. | 8.77 Million USD | -6604.321% |
| Kodiak Sciences Inc. | 213.59 Million USD | -175.341% |
| Annexon, Inc. | 47.11 Million USD | -1148.149% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -556.797% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -510.243% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4196.172% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 77.41% |
| Eyenovia, Inc. | 19.78 Million USD | -2873.178% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -232.1% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7556.594% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2340.363% |
| Arcellx, Inc. | 339.75 Million USD | -73.098% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -4842.873% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -139.514% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6049.775% |
| Moolec Science SA | 13.94 Million USD | -4117.196% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1262.864% |
| Geron Corporation | 146.12 Million USD | -302.46% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1063.823% |
| Royalty Pharma plc | 6.29 Billion USD | 90.661% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1378.537% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -199659.176% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -23803.886% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -210.909% |
| Humacyte, Inc. | 114.67 Million USD | -412.834% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1924.381% |
| 89bio, Inc. | 59.96 Million USD | -880.776% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2122.36% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -49072.492% |
| Genelux Corporation | 8.42 Million USD | -6884.596% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -8477.932% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -331.417% |
| Notable Labs, Ltd. | 4.42 Million USD | -13184.459% |
| Liquidia Corporation | 73.13 Million USD | -704.1% |
| Mustang Bio, Inc. | 17.61 Million USD | -3237.891% |
| Immunovant, Inc. | 48.95 Million USD | -1101.313% |
| Quantum-Si incorporated | 26.63 Million USD | -2108.34% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1432.197% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -18852.723% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -696.229% |
| Acasti Pharma Inc. | 11.55 Million USD | -4988.717% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2501.336% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21534.112% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1494.769% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -43052.691% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -9547.359% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2268.041% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2436.676% |
| PepGen Inc. | 34.63 Million USD | -1598.198% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -4742.745% |
| United Therapeutics Corporation | 1.18 Billion USD | 50.254% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -8320.719% |
| Solid Biosciences Inc. | 38.45 Million USD | -1429.208% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6772.616% |
| Immuneering Corporation | 12 Million USD | -4797.448% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -187278.687% |
| Silo Pharma, Inc. | 1.56 Million USD | -37376.215% |
| Belite Bio, Inc | 4.21 Million USD | -13865.875% |
| XOMA Corporation | 145.58 Million USD | -303.972% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -24121.705% |
| Bionomics Limited | 10.15 Million USD | -5689.144% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2636.508% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2466.678% |
| uniQure N.V. | 624.01 Million USD | 5.756% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4043.029% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -325356.417% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -245.569% |
| Forte Biosciences, Inc. | 3.66 Million USD | -15942.089% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -225587.401% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -8616.511% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7556.594% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3283.208% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5464.941% |
| Altimmune, Inc. | 16.54 Million USD | -3455.426% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 4.792% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2466.678% |
| Compugen Ltd. | 55.77 Million USD | -954.42% |
| Peak Bio, Inc. | 20.75 Million USD | -2733.772% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -432.398% |
| Benitec Biopharma Inc. | 4.96 Million USD | -11752.136% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -272.587% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -682.322% |
| Zura Bio Limited | 21.29 Million USD | -2662.084% |
| PolyPid Ltd. | 17.46 Million USD | -3266.745% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -423.228% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -682.322% |
| Instil Bio, Inc. | 99.8 Million USD | -489.276% |
| argenx SE | 444.95 Million USD | -32.173% |
| Immunome, Inc. | 28.65 Million USD | -1952.143% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -6954.132% |
| Verona Pharma plc | 58.84 Million USD | -899.478% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3963.449% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3857.891% |
| CervoMed Inc. | 2.59 Million USD | -22556.407% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -11966.126% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4517.643% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -5482.373% |
| Moolec Science SA | 13.94 Million USD | -4117.196% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -24995.029% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -957.829% |
| AnaptysBio, Inc. | 364.28 Million USD | -61.44% |
| Design Therapeutics, Inc. | 11.95 Million USD | -4818.894% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4536.574% |
| NeurAxis, Inc. | 1.91 Million USD | -30646.641% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1410.745% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4310.883% |
| Achilles Therapeutics plc | 19.08 Million USD | -2981.17% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3963.449% |
| 180 Life Sciences Corp. | 5.38 Million USD | -10816.655% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2393.231% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2483.963% |
| Nutriband Inc. | 1.07 Million USD | -54408.54% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1822.031% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3952.808% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -46.559% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1711.052% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4406.849% |
| Palisade Bio, Inc. | 2.73 Million USD | -21371.449% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -11095.564% |
| Beam Therapeutics Inc. | 478.38 Million USD | -22.935% |
| Neurogene Inc. | 36.54 Million USD | -1509.081% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -47.783% |
| AEON Biopharma, Inc. | 159.88 Million USD | -267.82% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1134.214% |
| Sesen Bio, Inc. | 30.98 Million USD | -1798.086% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2165.333% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -7635.942% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -200.454% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -206.213% |
| Athira Pharma, Inc. | 30.05 Million USD | -1856.626% |
| Vaccinex, Inc. | 5.94 Million USD | -9797.391% |
| HCW Biologics Inc. | 15.05 Million USD | -3807.157% |
| XOMA Corporation | 145.58 Million USD | -303.972% |
| Nektar Therapeutics | 267.04 Million USD | -120.225% |
| Arvinas, Inc. | 644.6 Million USD | 8.765% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3216.408% |
| Merus N.V. | 102.15 Million USD | -475.719% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -301.847% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -518.275% |
| Rezolute, Inc. | 11.73 Million USD | -4911.957% |
| Clene Inc. | 38.95 Million USD | -1409.853% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -20554.18% |
| BeyondSpring Inc. | 48.26 Million USD | -1118.387% |
| Synlogic, Inc. | 32.89 Million USD | -1687.819% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3924.519% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -35891.616% |
| Peak Bio, Inc. | 20.75 Million USD | -2733.772% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -826.745% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1380.846% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -56.143% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -490.649% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -135806.555% |
| MannKind Corporation | 721.36 Million USD | 18.474% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2533.101% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -28092.857% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -473.256% |
| Gossamer Bio, Inc. | 249.14 Million USD | -136.047% |
| CohBar, Inc. | 1.03 Million USD | -56796.418% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5401.946% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2987.479% |
| Legend Biotech Corporation | 589.93 Million USD | 0.31% |
| Mural Oncology plc | 37.92 Million USD | -1450.577% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -343.396% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -25521.697% |
| Disc Medicine, Inc. | 22.87 Million USD | -2470.942% |
| Champions Oncology, Inc. | 28.03 Million USD | -1997.746% |
| REGENXBIO Inc. | 262.22 Million USD | -124.272% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -17406.442% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -4592.062% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4278.494% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2673.417% |
| Vaxart, Inc. | 34.02 Million USD | -1628.444% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2784.376% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1961.214% |
| Cellectis S.A. | 249.57 Million USD | -135.642% |
| Longeveron Inc. | 5.33 Million USD | -10919.355% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1306.306% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 75.549% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -874.197% |
| Revolution Medicines, Inc. | 262.39 Million USD | -124.127% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -27811.865% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -6717.795% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4883.501% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4087.873% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -27240.911% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 88.58% |
| Denali Therapeutics Inc. | 122.96 Million USD | -378.276% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10468.09% |
| Veru Inc. | 32.81 Million USD | -1692.303% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -8461.697% |
| Cingulate Inc. | 10.36 Million USD | -5576.196% |
| Passage Bio, Inc. | 39.26 Million USD | -1397.894% |
| Context Therapeutics Inc. | 4.19 Million USD | -13930.128% |
| Exicure, Inc. | 8.54 Million USD | -6779.202% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1893.029% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -5508.459% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2568.223% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -260.83% |
| Nuvalent, Inc. | 31.82 Million USD | -1748.044% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -9144.538% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -833.171% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3167.239% |
| OmniAb, Inc. | 87.4 Million USD | -572.887% |
| Anew Medical, Inc. | 8.24 Million USD | -7035.614% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1435.954% |
| Lipocine Inc. | 2.63 Million USD | -22247.489% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2138.516% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1362.506% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2107.444% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -582.618% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -10788.78% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -610.724% |
| Ocugen, Inc. | 23.98 Million USD | -2352.166% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1167.272% |
| Q32 Bio Inc. | 233.12 Million USD | -152.266% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -6386.907% |
| Alumis Inc. Common Stock | 53.5 Million USD | -999.217% |
| Equillium, Inc. | 27.95 Million USD | -2003.598% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -184.669% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -10352.071% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -9489.207% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -273.812% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -747.008% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -5796.242% |
| Dominari Holdings Inc. | 4.63 Million USD | -12588.306% |
| Edesa Biotech, Inc. | 1.84 Million USD | -31833.709% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1889.052% |
| Bio-Techne Corporation | 744.34 Million USD | 20.99% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -366.382% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -70.734% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1349.422% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1930.953% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -536.751% |
| Nkarta, Inc. | 105.6 Million USD | -456.916% |
| BioCardia, Inc. | 4.59 Million USD | -12712.702% |
| Iterum Therapeutics plc | 32.66 Million USD | -1700.573% |